Significance and possible causes of false-negative results of reflex human papillomavirus infection testing

Cancer

Volumn 111, Issue 3, 2007, Pages 154-159

  Eltoum, Isam A ^a   Chhieng, David C ^a   Crowe, D Ralph ^a   Roberson, Janie ^a   Jin, Ge ^b   Broker, Thomas R ^b  

^a University of Alabama at Birmingham   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Atypical squamous cells of undetermined significance; Cervical intraepithelial neoplasia; Errors; False negative; Human papillomavirus infection; Quality

Indexed keywords

VIRUS DNA;

ARTICLE; CANCER GRADING; CANCER REGRESSION; CANCER RISK; CANCER STAGING; FALSE NEGATIVE RESULT; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUALITY CONTROL; UTERINE CERVIX BIOPSY; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY; VIRUS INFECTION; WART VIRUS;

ALGORITHMS; ALPHAPAPILLOMAVIRUS; CARCINOMA, SQUAMOUS CELL; CERVICAL INTRAEPITHELIAL NEOPLASIA; CYTODIAGNOSIS; DNA, VIRAL; FALSE NEGATIVE REACTIONS; FEMALE; HUMANS; PAPILLOMAVIRUS INFECTIONS; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; SEQUENCE ANALYSIS, DNA; UTERINE CERVICAL NEOPLASMS;

EID: 34250895173     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.22688     Document Type: Article

References (19)

1. Dehner LP. Cervicovaginal cytology, false-negative results, and standards of practice. Am J Clin Pathol. 1993;99:45-47.
2. Austin RM. Human papillomavirus reporting: minimizing patient and laboratory risk. Arch Pathol Lab Med. 2003;127:973-977.
3. Gill GW. Pap smear risk management by process control. Cancer (Cancer Cytopathol). 1997;81:198-211.
4. Helms PJ. 'Real world" pragmatic clinical trials: what are they and what do they tell us? Pediatr Allergy Immunol. 2002;13:4-9.
5. Godwin M, Ruhland L, Casson I, et al. Pragmatic controlled clinical trials in primary care: the struggle between external and internal validity. BMC Med Res Methodol. 2003;3:28. Available at URL: http://www. biomedcentral.com/1471-2288/3/28 Accessed February 5, 2007.
6. Hatem F, Wilbur DC. High grade squamous cervical lesions following negative Papanicolaou smears: false-negative cervical cytology or rapid progression. Diagn Cytopathol. 1995;12:135-141.
7. Wright TC Jr, Cox JT, Massad LS, Twiggs LB, Wilkinson EJ. 2001 Consensus Guidelines for the management of women with cervical cytological abnormalities. JAMA. 2002;287:2120-2129.
8. de Roda Husman AM, Snijders PJ, Stel HV, van den Brule AJ, Meijer CJ, Walboomers JM. Processing of long-stored archival cervical smears for human papillomavirus detection by the polymerase chain reaction. Br J Cancer. 1995;72:412-417.
9. Solomon D, Schiffman M, Tarone R, ALTS Study Group. Comparison of three management strategies for patients with atypical squamous cells of undetermined significance: baseline results from a randomized trial. J Natl Cancer Inst. 2001;93:293-299.
10. Arbyn M, Buntinx F, Van Ranst M, Paraskevaidis E, Martin-Hirsch P, Dillner J. Virologic versus cytologic triage of women with equivocal Pap smears: a meta-analysis of the accuracy to detect high-grade intraepithelial neoplasia. J Natl Cancer Inst. 2004;96:280-293.
11. Guyot A, Fox J, Karim S, Kyi M. Possible causes of low sensitivity of HPV-DNA testing for CIN2/3. Acta Obstet Gynecol Scand. 2004;83:217-218.
12. Husain OA, Butler EB, Evans DM, Macgregor JE, Yule R. Quality control in cervical cytology. J Clin Pathol. 1974;27:935-944.
13. Martin PL. How preventable is invasive cervical cancer? A community study of preventable factors. Am J Obstet Gynecol. 1972;113:541-548.
14. Barton SE, Jenkins D, Hollingworth A, Cuzick J, Singer A. An explanation for the problem of false-negative cervical smears. Br J Obstet Gynaecol. 1989;96:482-485.
15. O'Sullivan JP, A'Hern RP, Chapman PA, et al. A case-control study of true-positive versus false-negative cervical smears in women with cervical intraepithelial neoplasia (CIN III). Cytopathology. 1998;9:155-161.
16. Sherman ME, Wang SS, Tarone R, Rich L, Schiffman M. Histopathologic extent of cervical intraepithelial neoplasia 3 lesions in the Atypical Squamous Cells of Undetermined Significance Low-grade Squamous Intraepithelial Lesion Triage Study: implications for subject safety and lead-time bias. Cancer Epidemiol Biomarkers Prev. 2003;12:372-379.
17. Wheeler CM, Greer CE, Becker TM, Hunt WC, Anderson SM, Manos MM. Short-term fluctuations in the detection of cervical human papillomavirus DNA. Obstet Gynecol. 1996;88:261-268.
18. Nobbenhuis MA, Helmerhorst TJ, van den Brule AJ, et al. Cytological regression and clearance of high-risk human papillomavirus in women with an abnormal cervical smear. Lancet. 2001;358:1782-1783.
19. Jastania R, Geddie WR, Chapman W, Boemer S. Characteristics of apparently false-negative Digene Hybrid Capture 2 high-risk HPV DNA testing. Am J Clin Pathol. 2006;125: 223-228.